These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 32134564)
1. Hypoxia potentiates the capacity of melanoma cells to evade cisplatin and doxorubicin cytotoxicity via glycolytic shift. Zhuo M; Gorgun FM; Tyler DS; Englander EW FEBS Open Bio; 2020 May; 10(5):789-801. PubMed ID: 32134564 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Xu RH; Pelicano H; Zhou Y; Carew JS; Feng L; Bhalla KN; Keating MJ; Huang P Cancer Res; 2005 Jan; 65(2):613-21. PubMed ID: 15695406 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial respiration--an important therapeutic target in melanoma. Barbi de Moura M; Vincent G; Fayewicz SL; Bateman NW; Hood BL; Sun M; Suhan J; Duensing S; Yin Y; Sander C; Kirkwood JM; Becker D; Conrads TP; Van Houten B; Moschos SJ PLoS One; 2012; 7(8):e40690. PubMed ID: 22912665 [TBL] [Abstract][Full Text] [Related]
4. Calcium-Dependent Enhancement by Extracellular Acidity of the Cytotoxicity of Mitochondrial Inhibitors against Melanoma. Noguchi F; Inui S; Fedele C; Shackleton M; Itami S Mol Cancer Ther; 2017 May; 16(5):936-947. PubMed ID: 28223427 [TBL] [Abstract][Full Text] [Related]
5. Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatin. Kjønniksen I; Breistøl K; Fodstad O Cancer Res; 1992 Mar; 52(5):1347-51. PubMed ID: 1737396 [TBL] [Abstract][Full Text] [Related]
6. Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells. Wang Y; Ma J; Yan X; Chen X; Si L; Liu Y; Han J; Hao W; Zheng Q Recent Pat Anticancer Drug Discov; 2016; 11(2):215-27. PubMed ID: 26951491 [TBL] [Abstract][Full Text] [Related]
7. Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft. Mittal A; Tabasum S; Singh RP Phytomedicine; 2014 Feb; 21(3):340-7. PubMed ID: 24176840 [TBL] [Abstract][Full Text] [Related]
8. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants. Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452 [TBL] [Abstract][Full Text] [Related]